Search results
Your search for process/pmg6 returned no results
Showing 901 to 915 of 2854 results for process
Showing 901 to 915 of 2854 results for process
Awaiting development Reference number: GID-TA11199 Expected publication date: TBC
In development Reference number: GID-TA11866 Expected publication date: TBC
Nipocalimab for treating warm autoimmune haemolytic anaemia [ID6642]
Awaiting development Reference number: GID-TA11855 Expected publication date: TBC
Familial Breast Cancer: initial assessment and genetic testing (update)
In development Reference number: GID-NG10438 Expected publication date: 22 April 2027
Teprotumumab for treating thyroid eye disease (deferred appraisal of D1) [ID6756]
In development Reference number: GID-TA11995 Expected publication date: TBC
In development Reference number: GID-TAG509 Expected publication date: 28 September 2016
Our methods and processes (health technology evaluation manual)
NICE's technology appraisal and highly specialised technologies guidance manual
This guideline covers the clinical care of adults (18 years and over) who are dying during the last 2 to 3 days of life. It aims to improve end of life care for people in their last days of life by communicating respectfully and involving them, and the people important to them, in decisions and by maintaining their comfort and dignity. The guideline covers how to manage common symptoms without causing unacceptable side effects and maintain hydration in the last days of life.
NICE Advice works closely with our system partners and industry to drive innovation into the hands of health and care professionals, to enable best practice.
Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.
Awaiting development Reference number: GID-TA11308 Expected publication date: TBC
In development Reference number: GID-TA11766 Expected publication date: TBC
This guideline covers medicines adherence in people aged 18 and over. It recommends how to encourage adherence to medicines by supporting and involving people in decisions about their prescribed medicines. It aims to ensure that a person’s decision to use a medicine is an informed choice.
In development Reference number: GID-MT526 Expected publication date: TBC
Support for delivering quality, safety and efficiency in the optimisation of medicines.